Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 18.51 GBX -1.28% Market Closed
Market Cap: 76.3m GBX
Have any thoughts about
Creo Medical Group PLC?
Write Note

Gross Margin
Creo Medical Group PLC

49.5%
Current
42%
Average
47.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
49.5%
=
Gross Profit
15m
/
Revenue
30.3m

Gross Margin Across Competitors

Country UK
Market Cap 76.3m GBP
Gross Margin
50%
Country US
Market Cap 204.4B USD
Gross Margin
56%
Country US
Market Cap 183.9B USD
Gross Margin
67%
Country US
Market Cap 140.3B USD
Gross Margin
64%
Country US
Market Cap 125.1B USD
Gross Margin
69%
Country IE
Market Cap 114.5B USD
Gross Margin
66%
Country US
Market Cap 68.3B USD
Gross Margin
45%
Country DE
Market Cap 54B EUR
Gross Margin
38%
Country CN
Market Cap 338.2B CNY
Gross Margin
65%
Country US
Market Cap 40B USD
Gross Margin
41%
Country US
Market Cap 39.9B USD
Gross Margin
79%

Profitability Report

View the profitability report to see the full profitability analysis for Creo Medical Group PLC.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
49.5%
=
Gross Profit
15m
/
Revenue
30.3m
What is the Gross Margin of Creo Medical Group PLC?

Based on Creo Medical Group PLC's most recent financial statements, the company has Gross Margin of 49.5%.